Winsafe-DX Syrup is a combination pharmaceutical formulation containing Phenylephrine (5mg/5ml), Chlorpheniramine Maleate (2mg/5ml), and Dextromethorphan Hydrobromide (10mg/5ml), designed for the symptomatic relief of upper respiratory tract conditions. Phenylephrine acts as a selective alpha-1 adrenergic receptor agonist, providing effective nasal decongestion by vasoconstriction of nasal mucosa blood vessels. Chlorpheniramine Maleate, a first-generation antihistamine, alleviates allergic symptoms such as sneezing, rhinorrhea, and itching by antagonizing H1 histamine receptors. Dextromethorphan Hydrobromide serves as a centrally acting antitussive agent, suppressing the cough reflex through its action on the medullary cough center. This combination is indicated for the management of common cold, allergic rhinitis, sinusitis, and cough associated with upper respiratory infections. Winsafe-DX Syrup should be used with caution in patients with hypertension, glaucoma, or hyperthyroidism due to phenylephrine’s sympathomimetic effects. It is contraindicated in individuals with hypersensitivity to any component and in those taking monoamine oxidase inhibitors. Dosage should be adhered to as per medical advice to minimize adverse effects such as drowsiness, dizziness, dry mouth, or gastrointestinal disturbances. This formulation offers a comprehensive approach to managing multiple symptoms, enhancing patient comfort and recovery.